N/A N=32 Lifting and Tightening of the Face and Neck Following an Increased Density Treatment
Skin Laxity
Primary: Improvement in Overall Lifting and Tightening of Skin — 48 percentage of participants improved
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=24 Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study
Psoriasis
Primary: Proportion of Patients in the Study With Hypothalamic Pituitary Adrenal (HPA) Axis Suppression — 2; 3 participants
N/A N=102 Comparison of Pre-Induction Cervical Ripening
Failed Labour
Primary: Vaginal Delivery — 20; 21; 20 participants
Phase 2 N=356 AGN-199201 for the Treatment of Erythema With Rosacea
Rosacea · Erythema
Primary: Percentage of Participants With at Least a 2-Grade Decrease From Baseline on Both Clinician Erythema Assessment (CEA) and Subject Self-Assessment (SSA) — 13.3; 20.5…
N/A N=101 A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
Macular Edema
Primary: Peak Mean Change From Baseline in Best Corrected Visual Acuity (BCVA) — 6.3; 1.4 Lines
Phase 3 N=65 Hyper- and Hypokalemic Periodic Paralysis Study
Hyperkalemic Periodic Paralysis · Hypokalemic Periodic Paralysis
Primary: HYP Attack Rate — 0.9; 4.8 attacks per week
N/A N=64 Safety and Performance of New 1-piece Ostomy Product
Stoma Ileostomy
Primary: Degree of Leakage — 50; 44; 41; 60 percentage of baseplates with no leakage
N/A N=89 Study of Effect of Exercise With Osteoporosis and Vertebral Fracture
Osteoporosis · Vertebral Fracture
Primary: Time Used to Walk 20 m at Maximal Speed. — 14.9; 14.7; 13.4; 15.2 Seconds
Phase 3 N=33 Varenicline Treatment for Active Alcoholic Smokers
Smoking · Tobacco Dependence · Alcohol Dependence
Primary: Prolonged Smoking Abstinence at End of 12 Weeks of Varenicline Treatment — 6; 1 participants — p=0.034
Phase 2 N=89 Biomarkers of Cockroach Sublingual Immunotherapy 2
Asthma · Perennial Allergic Rhinitis
Primary: Change in German Cockroach-Specific Serum IgE Over Time — 2.0; 2.7; 1.2 Ratio — p=0.001
Phase 3 N=282 Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients
Liver Transplant Recipient
Primary: Incidence Rate of Composite Efficacy Failure Defined as Treated Biopsy Proven Acute Rejection (tBPAR ), Graft Loss or Death — 2; 1; 3 Participants
N/A N=22 Daytime Corneal Swelling During Wear of Narafilcon B Lenses
Myopia
Primary: Corneal Thickness — -0.35; -0.99; 0.75; -1.02 Percent Change — p=0.0035
Phase 4 N=125 A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides
Facial Rhytides
Primary: Percentage of Participants Satisfied With Treatment of Glabellar Lines Assessed Using the Facial Line Satisfaction Questionnaire (FLSQ) — 81.7; 0.0 Percentage of…
N/A N=91 The Clinical Effect of Low-Intensity Electromagnetic Field Neurostimulation in Fibromyalgia Syndrome Patients
Fibromyalgia
Primary: Change in Tender Point Pain Threshold — 19.6; -3.2 units on a scale
Phase 3 N=42 A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Fasting Plasma Glucose (FPG) — -27.6 mg/dL